Study of Alpha-blockers Alone During Preoperative Preparation in Patients With Pheochromocytoma

NCT ID: NCT05803330

Last Updated: 2023-04-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

95 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-20

Study Completion Date

2022-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study of the relationship between hemodynamic stability and preoperative intravenous rehydration in patients with pheochromocytoma

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients were subclassified into either the hemodynamic stability group (HS group) or the hemodynamic instability group (HU group) according to whether intraoperative hemodynamic instability occurred. Differences in data between the two groups were examined, and the risk factors for intraoperative hemodynamic instability were analyzed using logistic regression.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adrenal Pheochromocytoma Hemodynamic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PXB combined with venous dilation group

Use of PXB combined with intravenous volume expansion during preoperative preparation in patients with pheochromocytoma

Group Type NO_INTERVENTION

No interventions assigned to this group

PXB group

PXB alone during preoperative preparation in patients with pheochromocytoma

Group Type EXPERIMENTAL

Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma

Intervention Type DRUG

Abandonment of intravenous volume expansion with alpha-blockers during preoperative preparation in patients with pheochromocytoma

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma

Abandonment of intravenous volume expansion with alpha-blockers during preoperative preparation in patients with pheochromocytoma

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Clinical diagnosis of adrenal pheochromocytoma Must be able to swallow tablets

Exclusion Criteria

Bilateral or multiple pheochromocytomas. Ectopic pheochromocytoma
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kunwu Yan,MM

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kunwu Yan,MM

Research Project Leader

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

kunwu yan, Master

Role: PRINCIPAL_INVESTIGATOR

Handan First Hospital

References

Explore related publications, articles, or registry entries linked to this study.

Meijs AC, Snel M, Corssmit EPM. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas. Hormones (Athens). 2021 Jun;20(2):395-403. doi: 10.1007/s42000-021-00274-6. Epub 2021 Feb 11.

Reference Type BACKGROUND
PMID: 33575936 (View on PubMed)

Challis BG, Casey RT, Simpson HL, Gurnell M. Is there an optimal preoperative management strategy for phaeochromocytoma/paraganglioma? Clin Endocrinol (Oxf). 2017 Feb;86(2):163-167. doi: 10.1111/cen.13252. Epub 2016 Oct 24.

Reference Type BACKGROUND
PMID: 27696513 (View on PubMed)

Randle RW, Balentine CJ, Pitt SC, Schneider DF, Sippel RS. Selective Versus Non-selective alpha-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma. Ann Surg Oncol. 2017 Jan;24(1):244-250. doi: 10.1245/s10434-016-5514-7. Epub 2016 Aug 25.

Reference Type BACKGROUND
PMID: 27561909 (View on PubMed)

Bihain F, Nomine-Criqui C, Guerci P, Gasman S, Klein M, Brunaud L. Management of Patients with Treatment of Pheochromocytoma: A Critical Appraisal. Cancers (Basel). 2022 Aug 9;14(16):3845. doi: 10.3390/cancers14163845.

Reference Type BACKGROUND
PMID: 36010839 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

202303-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Diagnosis of Pheochromocytoma
NCT00004847 RECRUITING PHASE1
Study of Adrenal Gland Tumors
NCT00005927 COMPLETED